INO icon

Inovio Pharmaceuticals

133 hedge funds and large institutions have $32.1M invested in Inovio Pharmaceuticals in 2023 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 26 increasing their positions, 44 reducing their positions, and 63 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

less ownership

Funds ownership:

less funds holding

Funds holding:

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

60% less first-time investments, than exits

New positions opened: 25 | Existing positions closed: 63

68% less capital invested

Capital invested by funds: $99.8M → $32.1M (-$67.7M)

Holders
133
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$274K
Puts
$12K
Net Calls
Net Calls Change

Top Buyers

1 +$2.38M
2 +$1.25M
3 +$1.01M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$805K
5
Two Sigma Investments
Two Sigma Investments
New York
+$803K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$8.96M
2
$3.39M
3
$2.72M
4
$2.43M
5
$2.38M
6
$1.43M
7
$1.35M
8
$1.28M
9
$959K
10
$803K
11
$676K
12
$563K
13
$422K
14
$392K
15
$338K
16
$299K
17
$283K
18
$247K
19
$224K
20
$213K
21
$208K
22
$168K
23
$158K
24
$138K
25
$127K